/Innocutis launches buccal tablet for cold sores; New software tracks nanoparticles;
NEWS

Innocutis launches buccal tablet for cold sores; New software tracks nanoparticles;

FiercePharma
2014/07/22

Innocutis announced July 21 the launch of a 50 mg buccal tablet for cold sores. Release

The FDA issued a warning about pure caffeine bulk bags marketed directly to consumers over the internet. A teaspoon of pure caffeine is about equivalent to 25 cups of coffee, and can easily cause an overdose, leading to dangerously erratic heartbeat, seizures and even death. Notice

Malvern Instruments just launched NTA 3.0, an upgraded version of its software to track nanoparticles. More

Summary

> Innocutis announced July 21 the launch of a 50 mg buccal tablet for cold sores. Release > The FDA issued a warning about pure caffeine bulk bags marketed directly to consumers over the...